Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

3(75.0%)

Phase 1

1(25.0%)

4Total

N/A(3)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials

NCT03068988Phase 1Unknown

Clinical Study on Mesenchymal Stem Cells Used in the Reconstruction Surgery of the Supraspinatus Muscle Lesions

Role: lead

NCT02993679Not ApplicableCompleted

Stability of the Knee Joint After Anterior Cruciate Ligament and Anterolateral Ligament Reconstruction

Role: lead

NCT01391650Not ApplicableCompleted

Stability of the Knee Joint After Single and Double Bundle Anterior Cruciate Ligament Reconstruction

Role: lead

NCT01603836Not ApplicableCompleted

Study Confirms or Refutes the Hypothesis That the Autologous Bone Marrow Concentrate Together With the Allograft is a Better Alternative for the Posterolateral Fusion in Spine Surgery Than the Allograft Alone

Role: lead

All 4 trials loaded